{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:10:14Z","timestamp":1789560614021,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRMIST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018739","name":"Faculty of Science, Medicine and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100719","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:26:31Z","timestamp":1780676791000},"page":"100719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancements of mRNA-lipid nanoparticle links to gene editing and immune responses"],"prefix":"10.1016","volume":"24","author":[{"given":"Karthikeyan","family":"Sundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataraman","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.jgeb.2026.100719_bb0005","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle-mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100719_bb0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3324\/haematol.2018.210583","article-title":"Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA","volume":"105","author":"Russick","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100719_bb0015","first-page":"358","article-title":"Long-term storage of lipid-like nanoparticles for mRNA delivery","volume":"5","author":"Zhao","year":"2020","journal-title":"Bioact. Mater."},{"issue":"11","key":"10.1016\/j.jgeb.2026.100719_bb0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41551-018-0284-0","article-title":"Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA","volume":"2","author":"Islam","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jgeb.2026.100719_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120966","article-title":"Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles","volume":"275","author":"Kaczmarek","year":"2021","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100719_bb0030","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol. Ther."},{"issue":"19","key":"10.1016\/j.jgeb.2026.100719_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910603","article-title":"Comprehensive optimization of a freeze-drying process achieving enhanced long-term stability and in vivo performance of lyophilized mRNA-LNPs","volume":"25","author":"Alejo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2477384","article-title":"Lyophilized monkeypox mRNA lipid nanoparticle vaccines with long-term stability and robust immune responses in mice","volume":"21","author":"Wang","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.jgeb.2026.100719_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jgeb.2026.100719_bb0055","article-title":"PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jgeb.2026.100719_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114207","article-title":"Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA\/sgRNA for gene editing in vitro and in vivo","volume":"196","author":"Walther","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"32","key":"10.1016\/j.jgeb.2026.100719_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400783121","article-title":"In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells","volume":"121","author":"Palanki","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.jgeb.2026.100719_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0006","article-title":"Dynamically covalent lipid nanoparticles mediate CRISPR-Cas9 genome editing against choroidal neovascularization in mice","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0075","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41467-024-55137-6","article-title":"Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering","volume":"16","author":"Padilla","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32281-5","article-title":"Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo","volume":"13","author":"Ni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jgeb.2026.100719_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","article-title":"The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA","volume":"374","author":"Barbieri","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2377606","article-title":"A long-term stable cold-chain-friendly HIV mRNA vaccine encoding multi-epitope viral protease cleavage site immunogens inducing immunogen-specific protective T cell immunity","volume":"13","author":"Mandal","year":"2024","journal-title":"Emerg. Microbes. Infect."},{"issue":"9","key":"10.1016\/j.jgeb.2026.100719_bb0095","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.ymthe.2021.05.011","article-title":"Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection","volume":"29","author":"Knudson","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jgeb.2026.100719_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.omtn.2020.09.004","article-title":"The opposing effect of type I IFN on the T cell response by non-modified mRNA-Lipoplex vaccines is determined by the route of administration","volume":"22","author":"Van Hoecke","year":"2020","journal-title":"Mol. Ther. Nucleic. Acids"},{"issue":"6623","key":"10.1016\/j.jgeb.2026.100719_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6502","article-title":"Vaccination induces HIV broadly neutralizing antibody precursors in humans","volume":"378","author":"Leggat","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100719_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102372","article-title":"The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs","volume":"35","author":"D\u2019haese","year":"2024","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"3","key":"10.1016\/j.jgeb.2026.100719_bb0115","article-title":"Tetravalent immunogen assembled from conserved regions of HIV-1 and delivered as mRNA demonstrates potent preclinical T-cell immunogenicity and breadth","volume":"8","author":"Moyo","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jgeb.2026.100719_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.945706","article-title":"Comparative immunogenicity of an mRNA\/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques","volume":"13","author":"Valentin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jgeb.2026.100719_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"48","key":"10.1016\/j.jgeb.2026.100719_bb0130","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1016\/j.vaccine.2023.10.019","article-title":"Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice","volume":"41","author":"Hongtu","year":"2023","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100719_bb0135","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1016\/j.ymthe.2025.06.027","article-title":"mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models","volume":"33","author":"Limeres","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01382-5","article-title":"Natural killer cells in clinical development as non-engineered, engineered, and combination therapies","volume":"15","author":"Lamers-Kok","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.jgeb.2026.100719_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123542","article-title":"The tumor microenvironment-a metabolic obstacle to NK cells\u2019 activity","volume":"12","author":"Domagala","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jgeb.2026.100719_bb0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2023.08.014","article-title":"Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells","volume":"361","author":"Douka","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jgeb.2026.100719_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105599","article-title":"An LNP-mRNA vaccine modulates innate cell trafficking and promotes polyfunctional Th1 CD4+ T cell responses to enhance BCG-induced protective immunity against Mycobacterium tuberculosis","volume":"113","author":"Lukeman","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jgeb.2026.100719_bb0160","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/npjvaccines.2016.12","article-title":"Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice","volume":"1","author":"Counoupas","year":"2016","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100719_bb0165","article-title":"Lung IL-17A-producing CD4+ T cells correlate with protection after intrapulmonary vaccination with differentially adjuvanted tuberculosis vaccines","volume":"12","author":"Stewart","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"10.1016\/j.jgeb.2026.100719_bb0170","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.ymthe.2024.05.036","article-title":"In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection","volume":"32","author":"Tkaczyk","year":"2024","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.jgeb.2026.100719_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01832-20","article-title":"Multimechanistic monoclonal antibody combination targeting key Staphylococcus aureus virulence determinants in a rabbit model of prosthetic joint infection","volume":"65","author":"Mao","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60580-0","article-title":"An mRNA vaccine encoding five conserved Group A Streptococcus antigens","volume":"16","author":"Harbison-Price","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100719_bb0185","first-page":"592","article-title":"Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy","volume":"78","author":"Li","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100719_bb0190","article-title":"mRNA therapeutic vaccine for Hepatitis B demonstrates immunogenicity and efficacy in the AAV-HBV mouse model","volume":"12","author":"De Pooter","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jgeb.2026.100719_bb0195","first-page":"71","article-title":"Formulation and Delivery Technologies for mRNA Vaccines","volume":"440","author":"Zeng","year":"2022","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0200","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1038\/s41467-024-50087-5","article-title":"Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines","volume":"15","author":"Dong","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54289-9","article-title":"A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and na\u00efve non-human primates","volume":"15","author":"Vijayan","year":"2024","journal-title":"Nat. Commun."},{"issue":"66","key":"10.1016\/j.jgeb.2026.100719_bb0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj5129","article-title":"Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA","volume":"6","author":"Oh","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0215","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","article-title":"Efficient mRNA delivery to resting T cells to reverse HIV latency","volume":"16","author":"Cevaal","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0220","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1038\/s41467-023-44020-5","article-title":"Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir","volume":"14","author":"Pardons","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jgeb.2026.100719_bb0225","article-title":"Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets","volume":"68","author":"SLM","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jgeb.2026.100719_bb0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jgeb.2026.100719_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2023.03.039","article-title":"Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures","volume":"357","author":"Meulewaeter","year":"2023","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100719_bb0240","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.2c00032","article-title":"Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach","volume":"19","author":"Ly","year":"2022","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0245","doi-asserted-by":"crossref","first-page":"19590","DOI":"10.1038\/s41598-024-70680-4","article-title":"Impact of mixing and shaking on mRNA-LNP drug product quality characteristics","volume":"14","author":"Matthessen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jgeb.2026.100719_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115011","article-title":"A rapid and quantitative reversed-phase HPLC-DAD\/ELSD method for lipids involved in nanoparticle formulations","volume":"220","author":"Mousli","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jgeb.2026.100719_bb0255","article-title":"Biogenic fabrication of nanoparticles with Rhododendron arboreum: a multifunctional platform with antibacterial, anti-inflammatory, and anticancer therapeutic potential","volume":"17","author":"Saba","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jgeb.2026.100719_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2019.05.038","article-title":"Development and validation of a novel UPLC-ELSD method for the assessment of lipid composition of nanomedicine formulation","volume":"566","author":"Varache","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jgeb.2026.100719_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113967","article-title":"Development of HPLC-CAD stability indicating assay method for polyethylene glycol-conjugated phospholipid (DMPE-PEG 2000) and identification of its degradation products","volume":"198","author":"Kurmi","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"29","key":"10.1016\/j.jgeb.2026.100719_bb0270","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1007\/s00216-018-1388-9","article-title":"Chromatographic study of nucleoside-lipids by RP-UHPLC-DAD\/CAD","volume":"410","author":"Ferey","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jgeb.2026.100719_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122243","article-title":"Understanding structure activity relationships of Good HEPES lipids for lipid nanoparticle mRNA vaccine applications","volume":"301","author":"Goldman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jgeb.2026.100719_bb0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.09.006","article-title":"Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo","volume":"109","author":"Kauffman","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jgeb.2026.100719_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.123015","article-title":"Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations","volume":"1186","author":"Jia","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03309-9","article-title":"Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations","volume":"15","author":"Ho","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jgeb.2026.100719_bb0295","unstructured":"EMA, ICH Q2(R2) Validation of Analytical Procedures\u2014Scientific Guideline, Eur. [(accessed on 19 May 2024)]. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q2r2-guideline-validation-analytical-procedures-step-5-revision-1_en.pdf."},{"key":"10.1016\/j.jgeb.2026.100719_bb0300","author":"FDA"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100719_bb0305","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.3390\/ijms25115718","article-title":"Analytical ultracentrifugation to assess the quality of LNP-mRNA therapeutics","volume":"25","author":"Guerrini","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jgeb.2026.100719_bb0310","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jbm.a.37356","article-title":"Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery","volume":"110","author":"Zhang","year":"2022","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jgeb.2026.100719_bb0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2024.05.041","article-title":"Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tract","volume":"371","author":"Esih","year":"2024","journal-title":"J. Control. Release"},{"issue":"24","key":"10.1016\/j.jgeb.2026.100719_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado4791","article-title":"Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100719_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02506-23","article-title":"mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines","volume":"14","author":"Zhivaki","year":"2023","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0330","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12010-024-05031-0","article-title":"Phytomediated copper oxide nanoparticles derived from the fronds of adiantum venustum D.Don: evaluation of their biomedical potential","volume":"197","author":"Kimta","year":"2025","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60057-0","article-title":"Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses","volume":"16","author":"Meyer","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100719_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03201-8","article-title":"The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens","volume":"23","author":"Fernandes","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"10.1016\/j.jgeb.2026.100719_bb0345","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jgeb.2026.100719_bb0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from In Vitro-transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100719_bb0355","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jgeb.2026.100719_bb0360","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2022.08.009","article-title":"A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs","volume":"350","author":"Bogaert","year":"2022","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100719_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000057","article-title":"Fluorescence-based quantification of messenger RNA and plasmid DNA decay kinetics in extracellular biological fluids and cell extracts","volume":"4","author":"Zhang","year":"2020","journal-title":"Adv. Biosyst."}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:49:55Z","timestamp":1789559395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26000636"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100719","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements of mRNA-lipid nanoparticle links to gene editing and immune responses","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100719"}}